Clinical Trial Search

Primary: Graded and Redefined Assessment of Strength, Sensibility and Prehension Test (GRASSP Test) — 4.5; 19.4 score change before and after — p=<0.000

Primary: Electromyography — 0.00017507; 0.00006740 volts

Primary: Percent Change in Hmax — 27.85; 8.43; -4.91; 16.20 percent change in Hmax

Primary: Change in Walking Function - 10m Walk Walking Speed (m/s) — 0.06; 0.16 speed difference in meters per second

Primary: Number of Participants With Infection — 4; 3 Participants

Primary: Seated Systolic Blood Pressure — 86; 100.4; 102.7; 101.3 mmHg

Primary: Change in Step-length Symmetry Using Symmetry Index — 72.2; 75.8; 92.2; 76.0 Symmetry Index

Primary: Immediate Pain Measured by Numeric Pain Rating Scale (NPRS) — 4.89; 5.18 score on a scale

Primary: Montgomery Asberg Depression Rating Scale (MADRS) Score Change — -21.7; -14.6 summed total scores — p==0.040

Primary: Change in Visual Analog Scale (VAS) Score From Baseline to 2 Week Post Initial Fitting. — 35 participants with > 50% VAS improvement

Primary: Change in 10-Meter Walk Test (Interventional) — 0.18; -0.05 meters/second

Primary: Patient Perception of Bladder Condition Questionnaire — 3; 3 units on a scale

Primary: Safety of Using TTNS at Home Daily as Indicated by Number of Adverse Events Recorded in Bladder Diary — 0 adverse events

Primary: Mean Percent Change From Baseline in Area Under the Curve for Objectively Measured Spastic Catch Response of the Wrist Flexors at Fast Speed — 13.678; -8.783; 15.927…

Primary: 10-meter Walking Speed (m/Sec) — 0.165; 0.215; 0.13; 0.13 speed (m/sec)

Primary: Pain on 11-point Visual Analog Score Scale (VAS) — 3.52; 3.42; 4.44; 4.02 score on a scale — p=0.93

Primary: Electromyographic Responses (Active)

Primary: Muscle Weakness — 2; 3 Participants

Primary: Number of Subjects That Experienced ≥30% Reduction in Average Low Back Pain Intensity — 58 Participants

Primary: Pain as Assessed by Visual Analogue Scale (VAS) — 6.0; 5.9; 5.4; 5.3 units on a scale

Primary: Effectiveness of Expiratory Muscle Activation to Generate Large Airway Pressures Characteristic of Normal Cough. — 25; 121 cmH2O — p=<0.05

Primary: Change in Pain Level From Baseline to 45 Minutes — 1.2; 3.7 units on a scale

Primary: Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS) — 3.67; 3.33; 3.67; 3.33 score on a scale — p=0.2375

Primary: Subject Pain Relief — 56; 61 percentage of pain relief

Primary: Electromyography Response Amplitude — 33.7; 122.1; 39.2; 69.7 microvolts (mV) — p=<0.01

Primary: Pain Following Dilator Placement — 64; 60.5 units on a scale

Primary: Comparing Visual Analogue Scale (VAS) — 9.3; 8.6; 5.7; 4.9 score on a scale — p=0.112

Primary: Change in Spinal Cord Excitability as Measured by Percent Change in Soleus H-Reflex From Beginning of Session to End of the Same Session — -3.13 percent change in H-Reflex

Primary: Pain Assessment — -2.375; -1.625 units on a scale

Primary: Chemotherapy-induced Peripheral Neuropathy (CIPN) Symptoms — 32.32; 33.37 score on a scale — p=0.199